ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,308, issued on Aug. 5, was assigned to INVETX INC. (Boston).
"Anti-NGF antibodies and uses thereof" was invented by William Brondyk (Boston), Jordan Willis (Boston) and Leila Sevigny (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides novel anti-NGF proteins, antibodies, and NGF-binding fragments thereof which inhibit association of NGF with TrkA and/or p75 and are suitable for administration to a canine or feline subject. The invention also provides novel compositions and methods of treating pain or eliciting an analgesic effect in a canine or feline subject, comprising administering an effective amount of an anti-NGF prote...